Last updated on November 2017

A STUDY TO EVALUATE A PANEL OF BLOOD BIOMARKERS FOR USE IN PATIENTS UNDERGOING EVALUATION FOR LUNG CANCER, ONC-LN-04


Brief description of study

A STUDY TO EVALUATE A PANEL OF BLOOD BIOMARKERS FOR USE IN PATIENTS UNDERGOING EVALUATION FOR LUNG CANCER, ONC-LN-04

Detailed Study Description

Experimental tests, such as those used on the blood collected in this research study are also known as “investigational.” This means the tests have not been approved by the U.S. Food and Drug Administration (FDA).

In this research study, the accuracy of these blood tests will be determined by comparing the results with other tests as determined by your study doctor.

Clinical Study Identifier: TX15338

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Crystal Nagle

Reading Hospital Clinical Trials Office
West Reading, PA USA
  Connect »